Oruka Therapeutics, Inc. — Director's Dealing 2009

Jun 3, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARCA biopharma, Inc. (ABIO)
CIK: 0000907654
Period of Report: 2009-06-01

Reporting Person: Skyline Venture Partners Qualified Purchaser Fund IV L P (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-06-01	Common Stock	J	342375	—	Disposed	535208	Direct

Footnotes

F1: Pro rata distribution, for no consideration, by Skyline Venture Partners Qualified Purchaser Fund IV, L.P. to its limited partners.